Biofrontera Inc. Amortization of Intangible Assets
Biofrontera Inc. (BFRI) reported Amortization of Intangible Assets of $12.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2025-11-12
- Biofrontera Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $4.00K, a 96.33% decline year-over-year.
- Biofrontera Inc. amortization of intangible assets for the quarter ending 2025-06-30 was $4.00K, a 96.00% decline year-over-year.
- Biofrontera Inc. amortization of intangible assets for the quarter ending 2025-03-31 was $4.00K, a 96.26% decline year-over-year.
- Biofrontera Inc. amortization of intangible assets for the quarter ending 2024-12-31 was $4.00K, a 96.15% decline year-over-year.
- Biofrontera Inc. amortization of intangible assets for fiscal 2024 was $329.00K, a 21.29% decline from fiscal 2023.
- Biofrontera Inc. amortization of intangible assets for fiscal 2023 was $418.00K, a 0.00% change from fiscal 2022.
- Biofrontera Inc. amortization of intangible assets for fiscal 2022 was $418.00K.
- Biofrontera Inc. amortization of intangible assets for fiscal 2020 was $418.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2025-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $8.00K derived: sum of 2 quarters · filed 2025-11-12 | $12.00K 10-Q · filed 2025-11-12 | $16.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $8.00K 10-Q · filed 2025-08-13 | $12.00K derived: sum of 3 quarters · filed 2025-08-13 | $121.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $4.00K 10-Q · filed 2025-05-15 | $8.00K derived: sum of 2 quarters · filed 2025-05-15 | $117.00K derived: sum of 3 quarters · filed 2025-11-12 | $217.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $113.00K derived: sum of 2 quarters · filed 2025-11-12 | $213.00K derived: sum of 3 quarters · filed 2025-11-12 | $329.00K 10-K · filed 2025-03-20 |
| 2024-09-30 | $109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $209.00K derived: sum of 2 quarters · filed 2025-11-12 | $325.00K 10-Q · filed 2025-11-12 | $420.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $100.00K 10-Q · filed 2024-08-14 | $216.00K 10-Q · filed 2025-08-13 | $311.00K derived: sum of 3 quarters · filed 2025-05-15 | $411.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $107.00K 10-Q · filed 2025-05-15 | $211.00K derived: sum of 2 quarters · filed 2025-05-15 | $311.00K derived: sum of 3 quarters · filed 2025-05-15 | $411.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $204.00K derived: sum of 2 quarters · filed 2025-03-20 | $304.00K derived: sum of 3 quarters · filed 2025-03-20 | $418.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2024-08-14 | $314.00K 10-Q · filed 2024-11-14 | $409.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-06-30 | $100.00K 10-Q · filed 2024-08-14 | $209.00K 10-Q · filed 2024-08-14 | $309.00K derived: sum of 3 quarters · filed 2024-08-14 | $409.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $105.00K 10-Q · filed 2024-05-15 | $209.00K derived: sum of 2 quarters · filed 2024-05-15 | $309.00K derived: sum of 3 quarters · filed 2024-05-15 | $409.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | $204.00K derived: sum of 2 quarters · filed 2024-03-15 | $304.00K derived: sum of 3 quarters · filed 2024-03-15 | $418.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-09 | $200.00K derived: sum of 2 quarters · filed 2023-11-09 | $314.00K 10-Q · filed 2023-11-09 | $409.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-11 | $209.00K 10-Q · filed 2023-08-11 | $309.00K derived: sum of 3 quarters · filed 2023-10-03 | $409.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-03-31 | $105.00K 10-Q · filed 2023-05-12 | $209.00K derived: sum of 2 quarters · filed 2023-10-03 | $309.00K derived: sum of 3 quarters · filed 2023-10-03 | $413.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2021-12-31 | $104.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $204.00K derived: sum of 2 quarters · filed 2023-10-03 | $308.00K derived: sum of 3 quarters · filed 2023-10-03 | $418.00K 8-K · filed 2023-10-03 |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $204.00K derived: sum of 2 quarters · filed 2022-11-14 | $314.00K 10-Q · filed 2022-11-14 | $413.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $209.00K 10-Q · filed 2022-08-12 | $313.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $105.00K 10-Q · filed 2022-05-13 | $209.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | $418.00K 10-K · filed 2022-04-11 | ||
| 2020-09-30 | $314.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |